[HTML][HTML] Sepsis—pathophysiology and therapeutic concepts

D Jarczak, S Kluge, A Nierhaus - Frontiers in medicine, 2021 - frontiersin.org
Sepsis is a life-threatening condition and a global disease burden. Today, the
heterogeneous syndrome is defined as severe organ dysfunction caused by a dysregulated …

A new hope? Possibilities of therapeutic IgA antibodies in the treatment of inflammatory lung diseases

F Bohländer - Frontiers in Immunology, 2023 - frontiersin.org
Inflammatory lung diseases represent a persistent burden for patients and the global
healthcare system. The combination of high morbidity,(partially) high mortality and limited …

microRNA-124-3p attenuates myocardial injury in sepsis via modulating SP1/HDAC4/HIF-1α axis

M Wu, Z Huang, W Huang, M Lin, W Liu, K Liu… - Cell Death Discovery, 2022 - nature.com
Sepsis-induced cardiac dysfunction can lead to death in sepsis. In this case, we targeted to
explore in detail the relative mechanism of microRNA (miR)-124-3p in sepsis-induced …

[HTML][HTML] Precision medicine in sepsis and septic shock: From omics to clinical tools

JC Ruiz-Rodriguez, EP Plata-Menchaca… - World Journal of …, 2022 - ncbi.nlm.nih.gov
Sepsis is a heterogeneous disease with variable clinical course and several clinical
phenotypes. As it is associated with an increased risk of death, patients with this condition …

The role of the intravenous IgA and IgM-enriched immunoglobulin preparation in the treatment of sepsis and septic shock

G Berlot, S Zanchi, E Moro, A Tomasini… - Journal of Clinical …, 2023 - mdpi.com
Polyclonal Intravenous Immunoglobulins (IvIg) are often administered to critically ill patients
more as an act of faith than on the basis of relevant clinical studies. This particularly applies …

Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study

J Liu, Y Chen, R Li, Z Wu, Q Xu, Z Li, D Annane… - Clinical Microbiology …, 2021 - Elsevier
Objectives Intravenous immunoglobulin (IVIG) is commonly used to treat severe COVID-19,
although the clinical outcome of such treatment remains unclear. This study evaluated the …

Intravenous IgM-enriched immunoglobulins in critical COVID-19: a multicentre propensity-weighted cohort study

T Rahmel, F Kraft, H Haberl, U Achtzehn… - Critical Care, 2022 - Springer
Background A profound inflammation-mediated lung injury with long-term acute respiratory
distress and high mortality is one of the major complications of critical COVID-19 …

Clinical efficacy of IgM-enriched immunoglobulin as adjunctive therapy in neonatal and pediatric sepsis: a systematic review and meta-analysis

EC Dinleyici, G Frey, E Kola, U Wippermann… - Frontiers in …, 2023 - frontiersin.org
Background Sepsis is a major cause of mortality and morbidity globally, with around one-
quarter of all sepsis-related deaths occurring in children under the age of 5. We conducted a …

Destabilisation of T cell-dependent humoral immunity in sepsis

K Davies, JE McLaren - Clinical Science, 2024 - portlandpress.com
Sepsis is a heterogeneous condition defined as life-threatening organ dysfunction caused
by a dysregulated host response to infection. For some, sepsis presents as a predominantly …

Refractory Pseudomonas aeruginosa Bronchopulmonary Infection After Lung Transplantation for Common Variable Immunodeficiency Despite Maximal Treatment …

M Levêque, N Cassir, F Mathias, C Fevre… - Infection and Drug …, 2023 - Taylor & Francis
Recipients transplanted for bronchiectasis in the context of a primary immune deficiency,
such as common variable immunodeficiency, are at a high risk of severe infection in post …